相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study
Gianluca Trifio et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study
Frances Rees et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Role of Interleukin-1 Inhibitors in the Management of Gout
Tran H. Tran et al.
PHARMACOTHERAPY (2013)
Gout and its comorbidities: implications for therapy
Lisa K. Stamp et al.
RHEUMATOLOGY (2013)
Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial
Essack Mitha et al.
RHEUMATOLOGY (2013)
Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator
Robert A. Terkeltaub et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Initiation of Allopurinol at First Medical Contact for Acute Attacks of Gout: A Randomized Clinical Trial
Thomas H. Taylor et al.
AMERICAN JOURNAL OF MEDICINE (2012)
Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions
Naomi Schlesinger et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Purine-rich foods: an innocent bystander of gout attacks?
Pascal Richette et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: Results of a phase II randomized, double-blind, placebo-controlled trial
H. Ralph Schumacher et al.
ARTHRITIS AND RHEUMATISM (2012)
Challenges Associated with the Management of Gouty Arthritis in Patients with Chronic Kidney Disease: A Systematic Review
Rodolfo V. Curiel et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2012)
Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: Results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study
H. Ralph Schumacher et al.
ARTHRITIS CARE & RESEARCH (2012)
2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
Dinesh Khanna et al.
ARTHRITIS CARE & RESEARCH (2012)
Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout
Robert T. Keenan et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study
Naomi Schlesinger et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Novel Evidence-Based Colchicine Dose-Reduction Algorithm to Predict and Prevent Colchicine Toxicity in the Presence of Cytochrome P450 3A4/P-Glycoprotein Inhibitors
Robert A. Terkeltaub et al.
ARTHRITIS AND RHEUMATISM (2011)
Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies
Patricia McGettigan et al.
PLOS MEDICINE (2011)
Hyperuricaemia and gout: state of the art and future perspectives
Nicola Dalbeth et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Engagement of Fatty Acids With Toll-like Receptor 2 Drives Interleukin-1β Production via the ASC/Caspase 1 Pathway in Monosodium Urate Monohydrate Crystal-Induced Gouty Arthritis
Leo A. B. Joosten et al.
ARTHRITIS AND RHEUMATISM (2010)
Effect of Prophylaxis on Gout Flares After the Initiation of Urate-Lowering Therapy: Analysis of Data From Three Phase III Trials
Robert L. Wortmann et al.
CLINICAL THERAPEUTICS (2010)
Mechanisms of inflammation in gout
Nathalie Busso et al.
ARTHRITIS RESEARCH & THERAPY (2010)
The urate-lowering Efficacy and Safety of Febuxostat in the Treatment Hyperuricemia of Gout: The CONFIRMS trial
C. Dejaco et al.
JOURNAL FUR MINERALSTOFFWECHSEL (2010)
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Michael A. Becker et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Crystals of monosodium urate monohydrate enhance lipopolysaccharide-induced release of interleukin 1β by mononuclear cells through a caspase 1-mediated process
E. J. Giamarellos-Bourboulis et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Colchicine Update: 2008
Robert A. Terkeltaub
SEMINARS IN ARTHRITIS AND RHEUMATISM (2009)
Adherence with urate-lowering therapies for the treatment of gout
Leslie R. Harrold et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Effects of Febuxostat Versus Allopurinol and Placebo in Reducing Serum Urate in Subjects With Hyperuricemia and Gout: A 28-Week, Phase III, Randomized, Double-Blind, Parallel-Group Trial
H. Ralph Schumacher et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial
Hein J. E. M. Janssens et al.
LANCET (2008)
Determinants of the clinical outcomes of gout during the first year of urate-lowering therapy
Michael A. Becker et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2008)
Colchicine: Its mechanism of action and efficacy in crystal-induced inflammation
George Nuki
Current Rheumatology Reports (2008)
The role of interleukin-1 and the inflammasome in gout - Implications for therapy
Richard M. Pope et al.
ARTHRITIS AND RHEUMATISM (2007)
British Society for Rheumatology and British Health Professionals in rheumatology guideline for the management of gout
Kelsey M. Jordan et al.
RHEUMATOLOGY (2007)
Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: A double-blind, randomized, controlled trial
Chi Yin Man et al.
ANNALS OF EMERGENCY MEDICINE (2007)
A pilot study of IL-1 inhibition by anakinra in acute gout
Alexander So et al.
ARTHRITIS RESEARCH & THERAPY (2007)
EULAR evidence based recommendations for gout.: Part II:: Management.: Report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT)
W. Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Gout-associated uric acid crystals activate the NALP3 inflammasome
F Martinon et al.
NATURE (2006)
Febuxostat compared with allopurinol in patients with hyperuricemia and gout
MA Becker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
